Clinical Trial Imaging Market Projected To Exhibit Robust CAGR of 6.1% For The Forecast Period From 2021 To 2028: Grand View Research Inc.
The global clinical
trial imaging market
size is expected to reach USD 1.4
billion by 2028, according to a new report by Grand View Research, Inc. It
is expected to expand at a CAGR of 6.1%
from 2021 to 2028. The increasing R&D spending to develop new drugs and
therapies to treat chronic diseases is propelling the market growth.
Clinical trial
imaging makes use of imaging technology in clinical trials for seeing the
interior parts of the body. The images obtained from clinical trial imaging are
used to examine drug activity. Clinical trial imaging provides rapid, detail,
and precise screening. The use of clinical trial imaging has rapidly increased
in all phases of the clinical trials. Medical imaging in clinical trials is
used as a primary, quantitative, and surrogate biomarker.
The clinical
trial design includes selecting patient population, stratification based on
biomarkers, different methods for allocation treatments, choosing efficient and
reliable endpoints and validation of surrogate endpoints, calculating sample
size, trial simulations, adaptive trial set-up, statistical and interim
analysis, and assisting clients to deal with regulatory authorities, such as
EMA and FDA, to discuss study design or defend study results.
Market players
provide analytical testing services, pharmacokinetic, reading, and
pharmacodynamics services for enhanced clinical development. IXICO offers
advanced technologies for catalyzing clinical trials in neuroscience. Imaging
biomarkers by the company help in measuring the safety and effectiveness of
therapies used for neuroimaging. Imaging biomarkers are effective in
radiological reads. This provides a radiological reading of MRI scans for
central neuro to enhance the assessment of ongoing monitoring of drug safety
and subject eligibility.
Mounting
biotechnology and pharmaceutical industries, combined with increased research
and development investments for developing new drugs to treat diseases, are
expected to fuel the market growth. Medical imaging plays an active role in the
clinical development of novel life science products. Although the medical
imaging industry is in a constant state of fluctuation,
the biotechnology and pharmaceutical industries continue to increase.
This can be attributed to the enhanced investment in medical imaging companies,
mergers and acquisitions, and the adoption of innovative imaging technologies
to support clinical trials for the medical device. However, the high cost of
machinery and their installation and the enormous cost of clinical trials may
limit the market growth during the forecast period.
To Request Sample Copy of this report, click the link:
https://www.grandviewresearch.com/industry-analysis/clinical-trial-imaging-market/request/rs1
Clinical Trial Imaging Market Report Highlights
- Based on service,
project and data management services held the largest share in 2020 due to
the growing requirement of data management and workflow for clinical trial
imaging
- Operational
imaging services held a significant share in 2020. They include imaging
modalities such as MRI, CT scan, X-ray, ultrasound, OCT, PET, and SPECT.
CT scan modality is gaining popularity due to its non-invasive nature and
its ability to provide detailed information about the disease for enhanced
treatment
- The others
application segment held the largest share in 2020. This segment includes
oncology, neurology, and musculoskeletal. Market players such as ICON,
Bioclinica, Navitas Life Sciences, and Paraxel International are
developing their clinical trial imaging services for these applications
- By end-use, CROs
held the largest share in 2020 due to increasing investments in the field
of research and development and snowballing outsourcing activities by the
pharmaceutical and biotechnology companies to cut down the cost and time
and patent expiration
- North America
dominated the market in 2020 due to the increasing geriatric population,
rising chronic diseases, and growing demand for treatment options
List of Key Players of Clinical Trial Imaging Market
- Parexel
International Corporation
- Intrinsic Imaging
- Bioclinica Inc.
- Icon PLC
- Radiant Sage
- Navitas Life
Sciences
- Resonance Health
- IXICO PLC
- Medpace
Comments
Post a Comment